Folisurge 150 Injection
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Folisurge 150 Injection contains follitropin alfa, a recombinant human follicle-stimulating hormone (FSH). Its labelling describes it for the treatment of infertility in women who have trouble ovulating — by stimulating the ovaries to develop follicles and produce eggs, including in treatments such as IUI and IVF — and for male hypogonadism, used with human chorionic gonadotropin to support sperm production and balance certain hormones.
Product Information
The following description reflects information associated with follitropin alfa (recombinant human follicle-stimulating hormone) and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for stimulating the ovaries to develop follicles and produce eggs in women who have trouble ovulating
- Described as used in fertility treatments such as intrauterine insemination (IUI) and in vitro fertilisation (IVF)
- Described for male hypogonadism, used with human chorionic gonadotropin to support sperm production and balance certain hormones
Described Dosage & Administration
- Administered by a doctor as an injection — not self-administered
- The doctor sets the dose and the right time for the injection
- The frequency is set by the healthcare professional according to the reason for treatment
Described Side Effects
Commonly described side effects include:
- Allergic reactions
- Headache
- Breast swelling in men
- Injection-site reactions
These are described as usually settling as the body adjusts. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- The doctor should be told about any heart disease, thyroid disorder, or ovarian cysts
- The doctor should be asked whether the injection is safe alongside medicines for other conditions
- Pregnant women and breastfeeding mothers should consult their doctor before starting treatment
- Alcohol should not be consumed during the course of treatment
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains follitropin alfa, a recombinant human FSH used to stimulate the ovaries in women who have trouble ovulating, including in IUI and IVF, and for male hypogonadism together with human chorionic gonadotropin to support sperm production. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling states it is administered by a doctor as an injection. It is not self-administered, and the doctor sets the dose, timing, and frequency.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.